On January 24th, COINOTAG reported that Semler Scientific, a publicly traded company in the U.S., has made the strategic decision to **increase** its convertible preferred note offering to **$85 million**. This decision is aimed at enhancing the company’s **Bitcoin** acquisition strategies. Initially, the firm planned to issue **$75 million** worth of convertible preferred notes, set to mature in **2030**, specifically targeting qualified institutional investors. As part of this revised offering, Semler is providing initial purchasers with the option to acquire an additional **$15 million** in notes within a **13-day** window following the issuance date. Notably, the company intends to utilize a segment of the net proceeds from this offering to cover the costs associated with capped call transactions, while the remainder will serve **general corporate purposes**, including the procurement of **Bitcoin**.